We scale it down. Before we scale it up.
How we do it
Like all biomanufacturing, we start by identifying and selecting an appropriate blueprint for the desired compound or peptide from Nature.
_edited.png){kind=small}
Here is where it gets interesting.
We then miniaturise key biomanufacturing processes to our proprietory microfluidics platform.
This means replicating full-scale lab processes more efficiently on a chip that is no more than two-thirds the length of your pinkie.
1
1 inch
2
3
What can we do with our AI-enabled microfluidics platform?
1
Transplant the appropriate blueprint into multiple biofactories before separate them into individual cells
_edited.png){kind=small}
2
Use AI/ML to select the single BEST biofactory that optimally expresses target compound or peptide
3
Apply our patented encapsulation technology to the purified output for effective delivery across a wide range of applications
How do we scale it up?
Only the single BEST selected is scaled up.
This biofactory propagates and consumes sustainable feedstock in a bioreactor to produce larger volumes of the target compound or peptide
Why we do it better
By scaling our processes down, we reach new levels of efficiency. Since we work on a single cell level, we deliver unprecedented time and resource savings.
This makes our microfluidics platform more efficient than other incumbent technologies.
Up to a 100x times more.
​
LESS HUMAN RESOURCES
Complex operations are automated and seamlessly integrated into our platform technology
LOWER
COST
Our miniaturised process replaces large equipment and cuts reagent costs by 90%
ENHANCED SPEED
Parallel processing reduces the time to identify successful biofactories by 10x,
from months to a week
MORE SUSTAINABLE
Each reaction is carried out as a tiny droplet which means 1,000,000x less plastic, sample and reagent wastage
